Altimmune Inc (ALT)

Altimmune Inc (ALT) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $595M; returns 1 day -2.3%, 1 week -3.6%, 1 year -46.5%.

Altimmune Inc. (ALT) is a clinical-stage biopharmaceutical company focused on developing novel peptide-based therapeutics targeting obesity, metabolic dysfunction-associated steatohepatitis (MASH), and chronic liver diseases.

Groups ALT belongs to

• Biopharmaceutical
• Clinical Stage Biopharma
• GLP-1 Agonists
• Metabolic Disorders
• Weight Management
• Liver Disease
• Clinical Stage
• Biotechnology
• Healthcare
• NASH

ALT financial model: income statement, cash flow and balance sheet